Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Jun 19 | AXGN | Axogen, Inc. | MEXER | 14,150 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | XERS | Xeris Biopharma Holdings,… | AGRANT◷◆ | 32,996 | $6.15 | $202.9K | — | Open the original filing on SEC.gov |
| Jun 4 | XERS | Xeris Biopharma Holdings,… | AGRANT◷ | 24,193 | — | — | +3.5% | Open the original filing on SEC.gov |
| Jun 4 | XERS | Xeris Biopharma Holdings,… | SSELL◷ | 15,000 | $6.09 | $91.4K | -2.1% | Open the original filing on SEC.gov |
| May 21 | VSTM | Verastem, Inc. | AGRANT | 36,000 | — | — | +216.0% | Open the original filing on SEC.gov |
| May 7 | AXGN | Axogen, Inc. | MEXER◆ | 11,050 | — | — | — | Open the original filing on SEC.gov |
| May 7 | AXGN | Axogen, Inc. | SSELL | 11,050 | $43.26 | $478K | -100.0% | Open the original filing on SEC.gov |
| May 7 | AXGN | Axogen, Inc. | MEXER | 11,050 | $7.04 | $77.8K | — | Open the original filing on SEC.gov |
| Dec 19, 2025 | XERS | Xeris Biopharma Holdings,… | SSELL | 135,400 | $7.22 | $977K | -16.3% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AXGN | Axogen, Inc. | MEXER◆ | 8,545 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AXGN | Axogen, Inc. | SSELL | 13,141 | $29.98 | $394K | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AXGN | Axogen, Inc. | SSELL | 8,545 | $29.98 | $256.2K | -39.4% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AXGN | Axogen, Inc. | MEXER | 8,545 | $6.30 | $53.8K | +65.0% | Open the original filing on SEC.gov |
| Dec 8, 2025 | AXGN | Axogen, Inc. | MEXER◆ | 11,891 | — | — | — | Open the original filing on SEC.gov |
| Dec 8, 2025 | AXGN | Axogen, Inc. | SSELL | 11,891 | $31.22 | $371.3K | -47.5% | Open the original filing on SEC.gov |
| Dec 8, 2025 | AXGN | Axogen, Inc. | MEXER | 11,891 | $6.30 | $74.9K | +90.5% | Open the original filing on SEC.gov |
| Dec 8, 2025 | AXGN | Axogen, Inc. | SSELL | 11,802 | $31.26 | $368.9K | -47.3% | Open the original filing on SEC.gov |
| Aug 13, 2025 | XERS | Xeris Biopharma Holdings,… | SSELL | 107,500 | $7.32 | $786.5K | -11.4% | Open the original filing on SEC.gov |
| Jun 19, 2025 | AXGN | Axogen, Inc. | AGRANT◆ | 14,150 | — | — | — | Open the original filing on SEC.gov |
| Jun 9, 2025 | AXGN | Axogen, Inc. | SSELL | 4,073 | $10.61 | $43.2K | -14.0% | Open the original filing on SEC.gov |
| Jun 4, 2025 | XERS | Xeris Biopharma Holdings,… | AGRANT | 50,000 | — | — | +5.6% | Open the original filing on SEC.gov |
| May 22, 2025 | VSTM | Verastem, Inc. | AGRANT◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | VSTM | Verastem, Inc. | AGRANT | 8,333 | — | — | +100.0% | Open the original filing on SEC.gov |